Skip to content

Celcuity CELC Interest Expense

Interest Expense at other companies

Gilead Sciences logo
Gilead SciencesGILD
$240M-7.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$12.94M-28.6%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$1.21M
Tenet Healthcare logo
Tenet HealthcareTHC
$205M+0.5%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$5.12M-20.8%
Royalty Pharma logo
Royalty PharmaRPRX
$93.72M+43.6%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's interest expense?
Celcuity (CELC) reported interest expense of $6.09M in Q1 2026.
How has Celcuity's interest expense changed year-over-year?
Celcuity's interest expense increased by 91.2% year-over-year, from $3.18M to $6.09M.
What is the long-term trend for Celcuity's interest expense?
Over 4 years (2021 to 2025), Celcuity's interest expense has grown at a 92.0% compound annual growth rate (CAGR), from $1.26M to $17.15M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.